Financial Implication of Radioactive Iodine Therapy for Early-Stage Papillary Thyroid Cancer [0.03%]
早期分化型甲状腺癌患者行放射性碘治疗的经济因素分析
Zaid Al-Qurayshi,Daniah Bu Ali,Sudesh Srivastav et al.
Zaid Al-Qurayshi et al.
Objective: The aim of this study was to evaluate disease-specific survival and cost related to radioactive iodine therapy (RAI) utilization in patients with early-stage papillary thyroid carcinoma (PTC). ...
Outcomes in Melanoma Patients Treated with BRAF/MEK-Directed Therapy or Immune Checkpoint Inhibition Stratified by Clinical Trial versus Standard of Care [0.03%]
根据临床试验与标准治疗分层的黑色素瘤患者接受BRAF/MEK靶向治疗或免疫检查点抑制剂治疗的效果分析
Chloe Goldman,Jeremy Tchack,Eric M Robinson et al.
Chloe Goldman et al.
Objectives: Since 2011, metastatic melanoma treatment has evolved with commercial approval of BRAF- and MEK-targeted therapy and CTLA-4- and PD-1-blocking antibodies (immune checkpoint inhibitors, ICI). While novel therap...
Comparative Study
Oncology. 2017;93(3):164-176. DOI:10.1159/000475715 2017
Less Fibrotic Burden Differently Affects the Long-Term Outcomes of Hepatocellular Carcinoma after Curative Resection [0.03%]
较低的肝纤维化负担对完全切除后肝细胞癌长期结局的影响不同
Hye Won Lee,Gi Hong Choi,Do Young Kim et al.
Hye Won Lee et al.
Background: The clinical features of hepatocellular carcinoma (HCC) differ in patients with and without cirrhosis. Objective: We aimed ...
Comparative Study
Oncology. 2017;93(4):224-232. DOI:10.1159/000477173 2017
Surgery Is an Effective Option after Failure of Chemoradiation in Cancers of the Anal Canal and Anal Margin [0.03%]
化疗放疗失败后的肛管和肛门边缘癌症手术治疗的有效性评估
Jean-Baptiste Delhorme,François Severac,Waisse Waissi et al.
Jean-Baptiste Delhorme et al.
Background: Surgery for anal canal cancer (ACC) and anal margin cancer (AMC) is the only curative option after failure of chemoradiotherapy (CRT). This study aimed to determine the efficacy of surgery for ACC or AMC after...
ZNF750 Expression as a Novel Candidate Biomarker of Chemoradiosensitivity in Esophageal Squamous Cell Carcinoma [0.03%]
锌指抗凋亡蛋白ZNF750可能是食管鳞癌放化疗敏感性的候选标志物
Ryota Otsuka,Yasunori Akutsu,Haruhito Sakata et al.
Ryota Otsuka et al.
Objective: ZNF750, an epidermal differentiation regulator, has been suggested to act as a tumor suppressor of esophageal squamous cell carcinoma (ESCC). Although a correlation between the epidermal differentiation gene an...
Dual Inhibition of EGFR and VEGF in Heavily Pretreated Patients with Metastatic Colorectal Cancer [0.03%]
用于广泛预治疗的转移性结直肠癌患者的EGFR和VEGF双重抑制疗法
Finn Ole Larsen,Alice Markussen,Dorte Nielsen et al.
Finn Ole Larsen et al.
Objective: The aim of this study was to evaluate the efficacy and safety of combining irinotecan, bevacizumab, and cetuximab/panitumumab as a 4th-line treatment in patients with metastatic colorectal cancer. ...
Amrubicin Monotherapy for Patients with Platinum-Pretreated Non-Gastrointestinal Non-Pancreatic Extrapulmonary Neuroendocrine Carcinoma [0.03%]
用于铂类药物治疗后的非胃肠道非胰腺类外周神经内分泌癌患者的阿霉素单药治疗
Takahiro Ebata,Tatsunori Shimoi,Tsukasa Ishiwata et al.
Takahiro Ebata et al.
Objective: The aim of this study was to investigate the clinical usefulness of amrubicin therapy for patients with non-gastrointestinal (GI) non-pancreatic extrapulmonary neuroendocrine carcinoma (EP-NEC). ...
The Role of Audiometry prior to High-Dose Cisplatin in Patients with Head and Neck Cancer [0.03%]
头颈部癌症患者使用高剂量顺铂之前的听觉测试的作用
Miguel Caballero,Paula Mackers,Oscar Reig et al.
Miguel Caballero et al.
Objectives: To analyze the role of audiometry in considering change to a less ototoxic treatment in head and neck cancer (HNC) patients. Methods: ...
Clinical Trial
Oncology. 2017;93(2):75-82. DOI:10.1159/000468522 2017
Response Predictors of S-1, Cisplatin, and Docetaxel Combination Chemotherapy for Metastatic Gastric Cancer: Microarray Analysis of Whole Human Genes [0.03%]
S-1、顺铂和多西他赛联合化疗对胃癌晚期的作用预测因子：人类全基因微阵列分析
Shinji Kitamura,Toshihito Tanahashi,Eriko Aoyagi et al.
Shinji Kitamura et al.
Objectives: The aim of this study was to identify biomarkers for predicting the efficacy of docetaxel, cisplatin, and S-1 (DCS) therapy for advanced gastric cancer using microarrays of biopsy specimens before chemotherapy...
Clinical Trial
Oncology. 2017;93(2):127-135. DOI:10.1159/000464329 2017
Ezgi Bağırsakçı,Eren Şahin,Neşe Atabey et al.
Ezgi Bağırsakçı et al.
Objective: Levels of serum albumin have recently emerged, together with C-reactive protein, as an important prognostic indicator for hepatocellular carcinoma (HCC). It has recently been reported that larger HCCs are assoc...